Matthew L. Posard's Net Worth
Estimate Recalculated Nov 8, 2024 09:34PM EST
Who is Matthew L. Posard
Matthew L. Posard has an estimated net worth of $27.2 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, Nautilus Biotechnology, Inc., DermTech, Inc., HALOZYME THERAPEUTICS, INC., Trovagene, Inc., and Talis Biomedical Corp.
SEC CIK
Matthew L. Posard's CIK is 0001543792
Past Insider Trading and Trends
2013 was Matthew L. Posard's most active year for acquiring shares with 12 total transactions. Matthew L. Posard's most active month to acquire stocks was the month of April. 2013 was Matthew L. Posard's most active year for disposing of shares, totalling 19 transactions. Matthew L. Posard's most active month to dispose stocks was the month of March. 2021 saw Matthew L. Posard paying a total of $2,225,496.00 for 160,786 shares, this is the most they've acquired in one year. In 2013 Matthew L. Posard cashed out on 105,450 shares for a total of $3,170,096.48, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
